NCT03194984

Brief Summary

To evaluate the effectiveness in terms of color variation, patient satisfaction, absolute risk and intensity of dentin sensitivity due to dental bleaching in the office with 35% hydrogen peroxide (Whiteness HP Automixx 35%, FGM) and Opalescence Boost 38% ( Ultradent, South Jordan, UT, USA) in the same arch in patients of different age groups: 18 to 25 years and 40 to 65 years. Data will be collected, tabulated and submitted to statistical analysis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 22, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2018

Completed
Last Updated

February 13, 2018

Status Verified

February 1, 2018

Enrollment Period

9 months

First QC Date

May 23, 2017

Last Update Submit

February 9, 2018

Conditions

Keywords

dental whiteningDental office whitening

Outcome Measures

Primary Outcomes (1)

  • Tooth discoloration

    Efficacy of office dental whitening mensured by Easyshade spectrophotometer.

    36 weeks

Secondary Outcomes (2)

  • Dentin sensitivity

    36 weeks

  • Patient satisfaction

    36 weeks

Study Arms (2)

Young Patient

OTHER

With 18-25 years old. Drug: Hydrogen peroxide 35%. Drug: Hydrogen peroxide 38%

Drug: Hydrogen peroxide 35%Drug: Hydrogen peroxide 38%

Adult Patient

OTHER

With 40-65 years old. Drug: Hydrogen peroxide 35%. Drug: Hydrogen peroxide 38%

Drug: Hydrogen peroxide 35%Drug: Hydrogen peroxide 38%

Interventions

The office bleaching products will be applied on one of dental hemi-arch of young patients (18-25 years) or adult patients (40-65 years), after randomization. The product will apllied according manufacture instrutions.

Also known as: Hydrogen peroxide 38%
Adult PatientYoung Patient

The office bleaching products will be applied on one of dental hemi-arch of young patients (18-25 years) or adult patients (40-65 years), after randomization. The product will apllied according manufacture instrutions.

Also known as: Hydrogen peroxide 35%
Adult PatientYoung Patient

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age up to 25 years
  • Patients aged 40 years up to 65 years
  • Good oral and general health
  • Teeth free of restorations or with small restorations
  • Free from carious injury,
  • Patients with tooth color A2 or darker according to the Vita Classical color scale (Vita Zahnfabrik, Bad Säckingen, Germany)
  • Agree to the informed consent form

You may not qualify if:

  • extensive restoration
  • Patients who have already undergone dental whitening
  • Pregnant or lactating women
  • That report dental sensitivity
  • With non-carious cervical lesion
  • Parafunctional habits
  • Orthodontic appliances
  • Any other type of oral pathology
  • Smokers, patients who are using analgesic or anti-inflammatory drugs, present systemic alterations such as gastric, cardiac, renal and hepatic problems, diabetics, hypertensives or pre-existing neoplasias.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gisele Rodrigues da Silva

Uberlândia, Av Pará S/n Bloco 4 L Anexo A Sala 42 Campus Umuarama, Brazil

Location

Related Publications (4)

  • de Geus JL, Wambier LM, Kossatz S, Loguercio AD, Reis A. At-home vs In-office Bleaching: A Systematic Review and Meta-analysis. Oper Dent. 2016 Jul-Aug;41(4):341-56. doi: 10.2341/15-287-LIT. Epub 2016 Apr 5.

    PMID: 27045285BACKGROUND
  • Kossatz S, Dalanhol AP, Cunha T, Loguercio A, Reis A. Effect of light activation on tooth sensitivity after in-office bleaching. Oper Dent. 2011 May-Jun;36(3):251-7. doi: 10.2341/10-289-C. Epub 2011 Jul 8.

    PMID: 21740236BACKGROUND
  • Reis A, Dalanhol AP, Cunha TS, Kossatz S, Loguercio AD. Assessment of tooth sensitivity using a desensitizer before light-activated bleaching. Oper Dent. 2011 Jan-Feb;36(1):12-7. doi: 10.2341/10-148-CR. Epub 2011 Mar 24.

    PMID: 21488723BACKGROUND
  • Martin J, Rivas V, Vildosola P, Moncada L, Oliveira Junior OB, Saad JR, Fernandez E, Moncada G. Personality Style in Patients Looking for Tooth Bleaching and Its Correlation with Treatment Satisfaction. Braz Dent J. 2016 Jan-Feb;27(1):60-5. doi: 10.1590/0103-6440201600127.

    PMID: 27007348BACKGROUND

MeSH Terms

Conditions

Personal Satisfaction

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Gisele Silva, Dra

    Federal University of Uberlandia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
the patient did not know in which region each gel was applied the investigator did not know in which region each gel was applied the outcomes assessor did not know in which region each gel was applied
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: range of patients aged 18 to 25 years receiving two types of geis and range of patients aged 40-65 years receiving two types of geis
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professora

Study Record Dates

First Submitted

May 23, 2017

First Posted

June 22, 2017

Study Start

May 15, 2017

Primary Completion

January 30, 2018

Study Completion

January 30, 2018

Last Updated

February 13, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Metanalysis, systematic review (27045285)Access
Clinical Study Report (21740236)Access
Clinical Study Report (21488723)Access
Informed Consent Form (27007348)Access

Locations